Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

1.82
Delayed Data
As of Jan 18
 -0.02 / -1.09%
Today’s Change
1.66
Today|||52-Week Range
3.70
-0.55%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close1.84
Today’s open1.82
Day’s range1.80 - 1.84
Volume125,309
Average volume (3 months)329,516
Market cap$23.2M
Data as of 4:00pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)-10.56%
Earnings growth (next 5 years)--
Revenue growth (last year)-30.64%
P/E ratioNM
Price/Sales1.59
Price/Book0.45

Competitors

 Today’s
change
Today’s
% change
EBIOEleven Biotherapeuti...+0.01+1.26%
NVUSNovus Therapeutics I...+0.07+1.83%
RCKTRocket Pharmaceutica...-0.05-0.41%
TNXPTonix Pharmaceutical...+0.03+0.83%
Data as of 4:00pm ET, 01/18/2018

Financials

Next reporting dateFebruary 7, 2018
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$14.5M
Annual profit (last year)-$9.0M
Net profit margin-61.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Operations
Keith D. Hall
Corporate headquarters
San Diego, California

Forecasts